Abstract
Immune complexes are major pathogenic factors contributing to tissue injury in a number of autoimmune diseases. Immune complexes consist of autoantibodies to self-antigens, which initiate an inflammatory response through binding to immunoglobulin Fc receptors (FcRs) or via complement components. The significance of FcRs as regulators of inflammatory reactions was defined when mice with genetically engineered deficiencies of FcRs became available, giving new insight into the mechanisms involved in the pathogenesis of immune complex-mediated inflammation and autoimmunity. In this review, some of the most prominent work on inflammation and autoimmunity in animal models, will be presented. This body of knowledge has not only contributed to our understanding of the importance of FcRs in inflammatory autoimmune responses, but more specifically, has paved a new way for designing novel therapeutic compounds in treating autoimmune diseases.
Keywords: inflammation, autoimmunity, antibodies, fc receptors, animal models, knock outs
Current Pharmaceutical Design
Title: The Impact of Fc Receptors on the Development of Autoimmune Diseases
Volume: 9 Issue: 23
Author(s): S. Kleinau
Affiliation:
Keywords: inflammation, autoimmunity, antibodies, fc receptors, animal models, knock outs
Abstract: Immune complexes are major pathogenic factors contributing to tissue injury in a number of autoimmune diseases. Immune complexes consist of autoantibodies to self-antigens, which initiate an inflammatory response through binding to immunoglobulin Fc receptors (FcRs) or via complement components. The significance of FcRs as regulators of inflammatory reactions was defined when mice with genetically engineered deficiencies of FcRs became available, giving new insight into the mechanisms involved in the pathogenesis of immune complex-mediated inflammation and autoimmunity. In this review, some of the most prominent work on inflammation and autoimmunity in animal models, will be presented. This body of knowledge has not only contributed to our understanding of the importance of FcRs in inflammatory autoimmune responses, but more specifically, has paved a new way for designing novel therapeutic compounds in treating autoimmune diseases.
Export Options
About this article
Cite this article as:
Kleinau S., The Impact of Fc Receptors on the Development of Autoimmune Diseases, Current Pharmaceutical Design 2003; 9 (23) . https://dx.doi.org/10.2174/1381612033454414
DOI https://dx.doi.org/10.2174/1381612033454414 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Update on Pathogenesis of Sjogren's Syndrome
Current Rheumatology Reviews JAK3 Inhibitors in Organ Transplantation and Autoimmune Disease
Recent Patents on Inflammation & Allergy Drug Discovery Recent Advances in Regulatory T Cell Therapy of Autoimmunity, Graft Rejection and Cancer
Recent Patents on Inflammation & Allergy Drug Discovery Macrophage Migration Inhibitory Factor - A Favorable Marker in Inflammatory Diseases?
Current Medicinal Chemistry Autoimmunity-Inducing Metals (Hg, Au and Ag) Modulate Mast Cell Signaling, Function and Survival
Current Pharmaceutical Design Effect of Recombinant Human Thymosin-α1, an Immuno-Modulating Peptide with 28 Amino Acids, on the Activity of Cytochrome P450s
Drug Metabolism Letters Patients’ Induced Pluripotent Stem Cells to Model Drug Induced Adverse Events: A Role in Predicting Thiopurine Induced Pancreatitis?
Current Drug Metabolism Monoclonal Antibody-based Genetic Immunotherapy
Current Gene Therapy The Role of Chemokines in the Pathogenesis of Rheumatoid Arthritis
Current Rheumatology Reviews Neuropeptide Receptors in Intestinal Disease: Physiology and Therapeutic Potential
Current Pharmaceutical Design Sjogrens Syndrome and Lymphoma Development
Current Immunology Reviews (Discontinued) Platelet Activating Factor/Platelet Activating Factor Receptor Pathway as a Potential Therapeutic Target in Autoimmune Diseases
Inflammation & Allergy - Drug Targets (Discontinued) miRNA Functions in Arthritis
Current Rheumatology Reviews Multivalent Compounds for Antigen-Specific B Cell Tolerance and Treatment of Autoimmune Diseases
Current Medicinal Chemistry Biological Activities, Mechanisms of Action and Biomedical Prospect of the Antitumor Ether Phospholipid ET-18-OCH3 (Edelfosine), A Proapoptotic Agent in Tumor Cells
Current Drug Metabolism Radiolabelled Quinoline Derivaties for the PET Imaging of Peripheral Benzodiazepine Receptor
Current Medical Imaging Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Autoimmune Diseases and Atherosclerosis: The Inflammatory Connection
Current Immunology Reviews (Discontinued) Impact of Hydroxyl Radical Modified-Human Serum Albumin Autoantigens in Systemic Lupus Erythematosus
Current Protein & Peptide Science Targeting Cytokines of the Interleukin-12 Family in Autoimmunity
Current Medicinal Chemistry